Octopus Investments launches £20m joint fundraising

Two AIM VCTs

Octopus Investments is launching a £20m joint fundraising for two alternative investment market (AIM) VCTs.

The team - a part of Octopus Group - already runs several VCTs, including some AIM-dedicated ones. These new products would be made up of 90 companies, investing across a variety of sectors, including pharmaceuticals, biotech, healthcare services, software development and clean energy tech. The fundraising will allow investors access to Octopus AIM VCT plc (AIM VCT) and Octopus AIM VCT 2 plc (AIM VCT 2), which both target a 5% tax-free dividend yield every year. VCTs can enable investors to receive 30% income tax relief (as long as the shares are held for at least five years), tax fre...